T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$1.87B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.43B |
| 4 |
Apple
AAPL
|
+$1.28B |
| 5 |
PepsiCo
PEP
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.16B |
| 2 |
Amazon
AMZN
|
+$3.02B |
| 3 |
GE Aerospace
GE
|
+$2.2B |
| 4 |
Goldman Sachs
GS
|
+$1.76B |
| 5 |
Salesforce
CRM
|
+$1.43B |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.3% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Avidity Biosciences
RNA
$6.06B
| $105M | 0.02% |
6,864,385
+157,098
| +2% | +$2.41M |
|
502
Banco Santander Chile
BSAC
$12.2B
| $105M | 0.02% |
5,880,400
-387,496
| -6% | -$6.91M |
|
503
Magnolia Oil & Gas
MGY
$4.4B
| $103M | 0.02% |
4,719,376
-1,408,561
| -23% | -$30.8M |
|
504
Range Resources
RRC
$8.2B
| $103M | 0.02% |
3,897,553
+2,296,114
| +143% | +$60.8M |
|
505
Fortune Brands Innovations
FBIN
$7.07B
| $103M | 0.02% |
1,755,366
+863,931
| +97% | +$50.7M |
|
506
Johnson Controls International
JCI
$71.1B
| $102M | 0.02% |
1,698,594
+787,410
| +86% | +$47.4M |
|
507
Madison Square Garden
MSGS
$4.93B
| $102M | 0.02% |
523,511
+6,414
| +1% | +$1.25M |
|
508
Teradyne
TER
$18.3B
| $101M | 0.02% |
940,931
+569,516
| +153% | +$61.2M |
|
509
Coterra Energy
CTRA
$18.4B
| $101M | 0.02% |
4,108,552
+890,423
| +28% | +$21.9M |
|
510
Akero Therapeutics
AKRO
$3.47B
| $100M | 0.02% |
2,623,680
+222,643
| +9% | +$8.52M |
|
511
Unilever
UL
$154B
| $99.4M | 0.01% |
1,914,466
+283,105
| +17% | +$14.7M |
|
512
NiSource
NI
$19.1B
| $98.6M | 0.01% |
3,526,439
-2,769,439
| -44% | -$77.4M |
|
|
NIMC
513
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| – | – |
0
| – | -$97.6M |
|
|
JOYY
514
JOYY Inc. American Depositary Shares
JOYY
$3.23B
| $97.4M | 0.01% |
3,123,903
-794,269
| -20% | -$24.8M |
|
515
Republic Services
RSG
$71B
| $97.3M | 0.01% |
719,771
-3,199,579
| -82% | -$433M |
|
516
Replimune Group
REPL
$453M
| $97.1M | 0.01% |
5,495,616
+430,872
| +9% | +$7.61M |
|
517
Gartner
IT
$17.9B
| $96.7M | 0.01% |
296,899
-3,325
| -1% | -$1.08M |
|
518
Acadia Realty Trust
AKR
$2.55B
| $95.5M | 0.01% |
6,844,611
+1,025,776
| +18% | +$14.3M |
|
519
Huntington Ingalls Industries
HII
$10.5B
| $95.2M | 0.01% |
459,847
+375,553
| +446% | +$77.7M |
|
|
RXDX
520
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $95M | 0.01% |
885,332
+430,273
| +95% | +$46.2M |
|
521
Carlyle Group
CG
$23.4B
| $94.9M | 0.01% |
3,056,057
+1,088,182
| +55% | +$33.8M |
|
|
DFS
522
DELISTED
Discover Financial Services
DFS
| $94.1M | 0.01% |
952,531
+360,365
| +61% | +$35.6M |
|
523
Clean Harbors
CLH
$12.6B
| $93.7M | 0.01% |
656,973
+40,662
| +7% | +$5.8M |
|
|
DICE
524
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $93.3M | 0.01% |
3,255,430
+35,470
| +1% | +$1.02M |
|
525
Li Auto
LI
$24.3B
| $93.3M | 0.01% |
3,737,690
+796,070
| +27% | +$19.9M |
|